ExpreS2ion Biotech Holding AB (publ) Stock: price and insider trades · Sweden

ExpreS2ion Biotech Holding AB (publ), classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Finansinspektionen. Between 31 October 2025 and 31 October 2026, 1 insider published 3 filings.

Purchases and sales both appear in the filings: 1 purchase (1 insider, €14k) and 2 sales (1 insider, €106). Taken together, the purchases exceed the sales by €14k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 board member among the declarants. One trade stands out by size: a purchase of €14k from Martin Roland Holding ApS, disclosed on 4 May 2026.

Across the 1,035 companies tracked on its exchange, the median is 9 filings; at 3 filings, this issuer sits below that mark. Our records for ExpreS2ion Biotech Holding AB (publ) go back to 2023, with 1 purchase and 2 sales on the open market in total.

The last purchase on record was published on 4 May 2026, which is 188 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.